pyrazines has been researched along with Malaria, Falciparum in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ang, X; Bifani, P; Bodenreider, C; Bonamy, GMC; Chavchich, M; Dembele, L; Diagana, TT; Edstein, MD; Fidock, DA; Lim, MY; Nosten, F; Russell, BM; Selva, JJ; Straimer, J; Yeung, BKS | 1 |
| Abay, E; Basarab, GS; Brunschwig, C; Chibale, K; Gibhard, L; Lawrence, N; Njoroge, M; Paquet, T; Street, LJ; Taylor, D; Wiesner, L; Wittlin, S | 1 |
| Bu, W; Campo, B; Ding, J; Easom, EE; Freund, YR; Gamo, FJ; Ge, M; Guo, D; Jacobs, RT; Li, L; Plattner, JJ; Rosenthal, PJ; Sanders, V; Sanz, LM; Yang, Y; Zhang, YK | 1 |
| Ackermans, MT; canh Hung, N; Endert, E; Kager, PA; Sauerwein, HP; van Thien, H; Weverling, GJ | 1 |
1 trial(s) available for pyrazines and Malaria, Falciparum
| Article | Year |
|---|---|
FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria.
Topics: Adult; Alanine; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Glucose; Glycogen; Humans; Hypolipidemic Agents; Insulin; Interleukin-10; Lactic Acid; Malaria, Falciparum; Male; Pyrazines; Tumor Necrosis Factor-alpha | 2004 |
3 other study(ies) available for pyrazines and Malaria, Falciparum
| Article | Year |
|---|---|
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.
Topics: Animals; Antimalarials; Artemisinins; Cell Cycle Checkpoints; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrazines | 2017 |
Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria.
Topics: 1-Phosphatidylinositol 4-Kinase; Animals; Antimalarials; Biotransformation; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocytes; Gene Expression; Humans; Malaria, Falciparum; Male; Mice; Mice, Inbred NOD; Mice, SCID; Parasitemia; Plasmodium falciparum; Prodrugs; Pyrazines; Sulfones; Sulfoxides; Treatment Outcome | 2018 |
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
Topics: Animals; Antimalarials; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Survival; Female; Humans; Jurkat Cells; Malaria, Falciparum; Mice; Microsomes, Liver; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazines; Structure-Activity Relationship | 2015 |